COVID-19 Vaccines Unlikely To Create Litigation Opportunities

Retrieved on: 2020-12-07 23:15:00

Tags for this article:

Federal government of the United States

Health in the United States

Health

Public health emergency

United States Public Health Service

Public Readiness and Emergency Preparedness Act

CICP

COVID-19 vaccine

Emergency use authorization

United States Department of Health and Human Services

Alex Azar

Vaccine adverse event

Click the tags to see associated articles and topics

COVID-19 Vaccines Unlikely To Create Litigation Opportunities. View article details on hiswai:

Excerpt

... to treat COVID-19 infections, such as remdesivir[4] and <b>convalescent plasma</b>,[5] and will also likely be used by manufacturers of COVID-19 vaccines ...

Article found on: www.law360.com

View Original Article